Homeodex 09 12 D Granules is a Health Canada–registered human drug (DIN 02232215) held by Distributions Biodentcom Inc., containing Potassium Dichromate. Health Canada lists its status as Cancelled Post Market (status date 13 Sep 2007). Nexara Health has matched 15 registrations of Potassium Dichromate across 1 other regulated market, 8 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02232215 |
|---|---|
| Brand name | Homeodex 09 |
| Active ingredient | Potassium Dichromate |
| Strength | 12 D |
| Dosage form | Granules |
| Route | Oral |
| Company | Distributions Biodentcom Inc. |
| Status | Cancelled Post Market — 13 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Potassium Dichromate registered in other markets
15 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC | |
| United States | Kali bichromicum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Potassium Dichromate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Homeodex 09 (DIN 02232215) marketed in Canada?
No. Health Canada lists DIN 02232215 as Cancelled Post Market as of 13 Sep 2007.
Who holds the Canadian licence for this product?
Distributions Biodentcom Inc. is the company of record in the Health Canada Drug Product Database.
Is Potassium Dichromate registered outside Canada?
Yes — Nexara Health has matched 15 registrations in 1 other market, including 8 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02232215, status date 2007-09-13; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02232215, status date 2007-09-13; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02232215, status date 2007-09-13; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.